Related Experiment Video
Updated: Dec 18, 2025
07:14
Fabrication of a Biomimetic Nano-Matrix with Janus Base Nanotubes and Fibronectin for Stem Cell Adhesion
Published on: May 10, 2020
4.3K
Cell membrane-engineered hybrid soft nanocomposites for biomedical applications
Yuzhen Li1, Yingying Gan1, Chengnan Li1
1School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China. yuanpy3@mail.sysu.edu.cn dingxin3@mail.sysu.edu.cn.
Journal of Materials Chemistry. B
|June 11, 2020
Summary
Cell membrane-engineered hybrid soft nanocomposites combine natural cell membranes with synthetic nanoparticles for advanced biomedical applications. These hybrid nanocomposites show promise in drug delivery, cancer therapy, and bioimaging, offering enhanced biocompatibility and targeting.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Materials Science
Background:
- Cell membrane-engineered nanoparticles integrate natural cell membrane functions with synthetic nanoparticles.
- Cell membrane-engineered hybrid soft nanocomposites (CMHSNCs) feature a core of degradable macromolecules or biofunctional molecules and a functional cell membrane shell.
- These CMHSNCs offer superior biocompatibility, prolonged circulation, and enhanced targeting capabilities.
Purpose of the Study:
- To review recent advances in cell membrane-engineered hybrid soft nanocomposites (CMHSNCs).
- To discuss the application of CMHSNCs in delivering various cargoes, including drugs, genes, peptides, proteins, antigens/adjuvants, photoactivatable agents, and probes.
- To explore the challenges and future directions for CMHSNCs in fundamental research and clinical translation.
Main Methods:
- Review of recent scientific literature on cell membrane-engineered hybrid soft nanocomposites.
- Analysis of studies focusing on the design, fabrication, and application of CMHSNCs.
- Discussion of the properties and performance of CMHSNCs in various biomedical contexts.
Main Results:
- CMHSNCs have demonstrated significant potential in diverse biomedical applications such as cancer therapy, bioimaging, detoxification, anti-virulence, and thrombolysis.
- These nanocomposites effectively deliver a wide range of therapeutic and diagnostic cargoes.
- The hybrid structure provides enhanced biocompatibility, extended circulation times, and improved targeting efficiency.
Conclusions:
- Cell membrane-engineered hybrid soft nanocomposites represent a promising platform for advanced drug delivery and theranostics.
- Further research and development are crucial for overcoming current challenges and facilitating clinical translation of CMHSNCs.
- The unique properties of CMHSNCs pave the way for innovative solutions in personalized medicine and regenerative therapies.
